title: Phase 1 trials of molecular targeted therapies: are we evaluating toxicities properly?
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Soria
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology* / Q000633:toxicity*; D017321:Clinical Trials, Phase I as Topic; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D009369:Neoplasms / Q000188:drug therapy*; D018675:Toxicity Tests / Q000592:standards*
chemical_list: D000970:Antineoplastic Agents